vs

Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and Astera Labs, Inc. (ALAB). Click either name above to swap in a different company.

Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $172.2M, roughly 1.6× Acadian Asset Management Inc.). Acadian Asset Management Inc. runs the higher net margin — 20.2% vs 16.6%, a 3.5% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 2.6%). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 27.6%).

United Asset Management was an American holding company headquartered in Boston, Massachusetts.

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

AAMI vs ALAB — Head-to-Head

Bigger by revenue
ALAB
ALAB
1.6× larger
ALAB
$270.6M
$172.2M
AAMI
Growing faster (revenue YoY)
ALAB
ALAB
+89.2% gap
ALAB
91.8%
2.6%
AAMI
Higher net margin
AAMI
AAMI
3.5% more per $
AAMI
20.2%
16.6%
ALAB
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
27.6%
AAMI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AAMI
AAMI
ALAB
ALAB
Revenue
$172.2M
$270.6M
Net Profit
$34.7M
$45.0M
Gross Margin
75.6%
Operating Margin
33.3%
24.7%
Net Margin
20.2%
16.6%
Revenue YoY
2.6%
91.8%
Net Profit YoY
-18.4%
82.0%
EPS (diluted)
$0.97
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAMI
AAMI
ALAB
ALAB
Q4 25
$172.2M
$270.6M
Q3 25
$144.2M
$230.6M
Q2 25
$127.4M
$191.9M
Q1 25
$119.9M
$159.4M
Q4 24
$167.8M
$141.1M
Q3 24
$123.1M
$113.1M
Q2 24
$109.0M
$76.8M
Q1 24
$105.7M
$65.3M
Net Profit
AAMI
AAMI
ALAB
ALAB
Q4 25
$34.7M
$45.0M
Q3 25
$15.1M
$91.1M
Q2 25
$10.1M
$51.2M
Q1 25
$20.1M
$31.8M
Q4 24
$42.5M
$24.7M
Q3 24
$16.9M
$-7.6M
Q2 24
$11.0M
$-7.5M
Q1 24
$14.6M
$-93.0M
Gross Margin
AAMI
AAMI
ALAB
ALAB
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Q1 24
77.4%
Operating Margin
AAMI
AAMI
ALAB
ALAB
Q4 25
33.3%
24.7%
Q3 25
18.4%
24.0%
Q2 25
12.7%
20.7%
Q1 25
26.6%
7.1%
Q4 24
38.7%
0.1%
Q3 24
21.9%
-7.9%
Q2 24
18.9%
-31.7%
Q1 24
21.7%
-127.1%
Net Margin
AAMI
AAMI
ALAB
ALAB
Q4 25
20.2%
16.6%
Q3 25
10.5%
39.5%
Q2 25
7.9%
26.7%
Q1 25
16.8%
20.0%
Q4 24
25.3%
17.5%
Q3 24
13.7%
-6.7%
Q2 24
10.1%
-9.8%
Q1 24
13.8%
-142.5%
EPS (diluted)
AAMI
AAMI
ALAB
ALAB
Q4 25
$0.97
$0.25
Q3 25
$0.42
$0.50
Q2 25
$0.28
$0.29
Q1 25
$0.54
$0.18
Q4 24
$1.11
$1.23
Q3 24
$0.45
$-0.05
Q2 24
$0.29
$-0.05
Q1 24
$0.37
$-1.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAMI
AAMI
ALAB
ALAB
Cash + ST InvestmentsLiquidity on hand
$167.6M
Total DebtLower is stronger
$200.0M
Stockholders' EquityBook value
$1.4B
Total Assets
$677.0M
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAMI
AAMI
ALAB
ALAB
Q4 25
$167.6M
Q3 25
$140.4M
Q2 25
$162.3M
Q1 25
$86.4M
Q4 24
$79.6M
Q3 24
$126.1M
Q2 24
$421.1M
Q1 24
$696.1M
Total Debt
AAMI
AAMI
ALAB
ALAB
Q4 25
$200.0M
Q3 25
Q2 25
Q1 25
Q4 24
$275.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AAMI
AAMI
ALAB
ALAB
Q4 25
$1.4B
Q3 25
$1.3B
Q2 25
$1.1B
Q1 25
$1.0B
Q4 24
$964.8M
Q3 24
$889.6M
Q2 24
$845.3M
Q1 24
$808.8M
Total Assets
AAMI
AAMI
ALAB
ALAB
Q4 25
$677.0M
$1.5B
Q3 25
$751.4M
$1.4B
Q2 25
$672.3M
$1.3B
Q1 25
$677.3M
$1.1B
Q4 24
$703.2M
$1.1B
Q3 24
$555.2M
$983.1M
Q2 24
$533.1M
$915.5M
Q1 24
$544.9M
$864.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAMI
AAMI
ALAB
ALAB
Operating Cash FlowLast quarter
$-2.4M
$95.3M
Free Cash FlowOCF − Capex
$76.6M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
-0.07×
2.12×
TTM Free Cash FlowTrailing 4 quarters
$281.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAMI
AAMI
ALAB
ALAB
Q4 25
$-2.4M
$95.3M
Q3 25
$-23.9M
$78.2M
Q2 25
$61.6M
$135.4M
Q1 25
$-48.8M
$10.5M
Q4 24
$55.8M
$39.7M
Q3 24
$69.6M
$63.5M
Q2 24
$45.7M
$29.8M
Q1 24
$-40.4M
$3.7M
Free Cash Flow
AAMI
AAMI
ALAB
ALAB
Q4 25
$76.6M
Q3 25
$65.9M
Q2 25
$133.3M
Q1 25
$6.0M
Q4 24
$24.3M
Q3 24
$46.8M
Q2 24
$28.5M
Q1 24
$228.0K
FCF Margin
AAMI
AAMI
ALAB
ALAB
Q4 25
28.3%
Q3 25
28.6%
Q2 25
69.5%
Q1 25
3.7%
Q4 24
17.2%
Q3 24
41.4%
Q2 24
37.1%
Q1 24
0.3%
Capex Intensity
AAMI
AAMI
ALAB
ALAB
Q4 25
6.9%
Q3 25
5.3%
Q2 25
1.1%
Q1 25
2.8%
Q4 24
10.9%
Q3 24
14.8%
Q2 24
1.7%
Q1 24
5.2%
Cash Conversion
AAMI
AAMI
ALAB
ALAB
Q4 25
-0.07×
2.12×
Q3 25
-1.58×
0.86×
Q2 25
6.10×
2.64×
Q1 25
-2.43×
0.33×
Q4 24
1.31×
1.61×
Q3 24
4.12×
Q2 24
4.15×
Q1 24
-2.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons